|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Erkan M, Hausmann S, Michalski CW, et al:
The role of stroma in pancreatic cancer: diagnostic and therapeutic
implications. Nat Rev Gastroenterol Hepatol. 9:454–467. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wong HH and Lemoine NR: Pancreatic cancer:
molecular pathogenesis and new therapeutic targets. Nat Rev
Gastroenterol Hepatol. 6:412–422. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Olive KP, Jacobetz MA, Davidson CJ, et al:
Inhibition of Hedgehog signaling enhances delivery of chemotherapy
in a mouse model of pancreatic cancer. Science. 324:1457–1461.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garrido-Laguna I, Uson M, Rajeshkumar NV,
et al: Tumor engraftment in nude mice and enrichment in
stroma-related gene pathways predict poor survival and resistance
to gemcitabine in patients with pancreatic cancer. Clin Cancer Res.
17:5793–5800. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Terry SY and Vallis KA: Relationship
between chromatin structure and sensitivity to molecularly targeted
auger electron radiation therapy. Int J Radiat Oncol Biol Phys.
83:1298–1305. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ng HH, Jeppesen P and Bird A: Active
repression of methylated genes by the chromosomal protein MBD1. Mol
Cell Biol. 20:1394–1406. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lopez-Serra L, Ballestar E, Fraga MF,
Alaminos M, Setien F and Esteller M: A profile of methyl-CpG
binding domain protein occupancy of hypermethylated promoter CpG
islands of tumor suppressor genes in human cancer. Cancer Res.
66:8342–8346. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu C, Chen Y, Yu X, et al: Proteomic
analysis of differential proteins in pancreatic carcinomas: effects
of MBD1 knockdown by stable RNA interference. BMC Cancer.
8:1212008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Watanabe S, Ichimura T, Fujita N, et al:
Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase
link transcriptional repression and DNA repair in chromatin. Proc
Natl Acad Sci USA. 100:12859–12864. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Chen LH, Wang L, Wang HM, Zhang
YW and Shi YS: Radiation-inducible PTEN expression radiosensitises
hepatocellular carcinoma cells. Int J Radiat Biol. 86:964–974.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K
and Linn S: Molecular mechanisms of mammalian DNA repair and the
DNA damage checkpoints. Annu Rev Biochem. 73:39–85. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bekker-Jensen S, Lukas C, Kitagawa R, et
al: Spatial organization of the mammalian genome surveillance
machinery in response to DNA strand breaks. J Cell Biol.
173:195–206. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jirawatnotai S, Hu Y, Michowski W, et al:
A function for cyclin D1 in DNA repair uncovered by protein
interactome analyses in human cancers. Nature. 474:230–234. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Löbrich M, Shibata A, Beucher A, et al:
gammaH2AX foci analysis for monitoring DNA double-strand break
repair: strengths, limitations and optimization. Cell Cycle.
9:662–669. 2010.PubMed/NCBI
|
|
16
|
Bartkova J, Horejsí Z, Koed K, et al: DNA
damage response as a candidate anti-cancer barrier in early human
tumorigenesis. Nature. 434:864–870. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kastan MB and Bartek J: Cell-cycle
checkpoints and cancer. Nature. 432:316–323. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chapman JR and Jackson SP:
Phospho-dependent interactions between NBS1 and MDC1 mediate
chromatin retention of the MRN complex at sites of DNA damage. EMBO
Rep. 9:795–801. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Harper JW and Elledge SJ: The DNA damage
response: ten years after. Mol Cell. 28:739–745. 2007.PubMed/NCBI
|
|
20
|
Zhou BB and Elledge SJ: The DNA damage
response: putting checkpoints in perspective. Nature. 408:433–439.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yao W, Yu X, Fang Z, et al: Profilin1
facilitates staurosporine-triggered apoptosis by stabilizing the
integrin betal-actin complex in breast cancer cells. J Cell Mol
Med. 16:824–835. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shibamoto Y, Kubota T, Kishii K and
Tsujitani M: Radiosensitivity of human pancreatic cancer cells in
vitro and in vivo, and the effect of a new hypoxic cell sensitizer,
doranidazole. Radiother Oncol. 56:265–270. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim MP and Gallick GE: Gemcitabine
resistance in pancreatic cancer: picking the key players. Clin
Cancer Res. 14:1284–1285. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Parsels LA, Morgan MA, Tanska DM, et al:
Gemcitabine sensitization by checkpoint kinase 1 inhibition
correlates with inhibition of a Rad51 DNA damage response in
pancreatic cancer cells. Mol Cancer Ther. 8:45–54. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krempler A, Deckbar D, Jeggo PA and
Lobrich M: An imperfect G2M checkpoint contributes to chromosome
instability following irradiation of S and G2 phase cells. Cell
Cycle. 6:1682–1686. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bartek J and Lukas J: Mammalian G1- and
S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol.
13:738–747. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Taverna SD, Li H, Ruthenburg AJ, Allis CD
and Patel DJ: How chromatin-binding modules interpret histone
modifications: lessons from professional pocket pickers. Nat Struct
Mol Biol. 14:1025–1040. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mailand N, Falck J, Lukas C, et al: Rapid
destruction of human Cdc25A in response to DNA damage. Science.
288:1425–1429. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Helt CE, Cliby WA, Keng PC, Bambara RA and
O’Reilly MA: Ataxia telangiectasia mutated (ATM) and ATM and
Rad3-related protein exhibit selective target specificities in
response to different forms of DNA damage. J Biol Chem.
280:1186–1192. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Falck J, Mailand N, Syljuasen RG, Bartek J
and Lukas J: The ATM-Chk2-Cdc25A checkpoint pathway guards against
radioresistant DNA synthesis. Nature. 410:842–847. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kouzarides T: Snapshot: histone-modifying
enzymes. Cell. 131:8222007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stucki M, Clapperton JA, Mohammad D, Yaffe
MB, Smerdon SJ and Jackson SP: MDC1 directly binds phosphorylated
histone H2AX to regulate cellular responses to DNA double-strand
breaks. Cell. 123:1213–1226. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu L, Luo K, Lou Z and Chen J: MDC1
regulates intra-S-phase checkpoint by targeting NBS1 to DNA
double-strand breaks. Proc Natl Acad Sci USA. 105:11200–11205.
2008. View Article : Google Scholar : PubMed/NCBI
|
